Keith A. Goldan - Jun 13, 2022 Form 3 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Signature
/s/ Michael A. Metzger, Attorney-in-Fact
Stock symbol
SNDX
Transactions as of
Jun 13, 2022
Transactions value $
$0
Form type
3
Date filed
6/15/2022, 04:05 PM
Previous filing
Mar 17, 2022
Next filing
Feb 3, 2023

No securities are beneficially owned.